← Leaderboards
Ralph Eugene Hurd
University Of California, San Francisco
$2,412,854
Attributed
$7,238,563
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2010–18$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$7,238,563 · 3
By mechanism
R01$7,238,563 · 3
Top collaborators
- Daniel B Vigneron10 shared
- John Kurhanewicz7 shared
- Pamela N Munster5 shared
- Marcus Ferrone2 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Daniel B Vigneron$43,424,992
- Peder Eric Zufall Larson$7,557,566
- Jeremy William Gordon$6,602,958
- Sabrina Miriam Ronen$18,398,578
- Myriam Marianne Chaumeil$7,418,051
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsCancer PatientMetabolicImageResponseImaging TechniquesImaging DeviceMalignant Neoplasm Of ProstatePyruvatePre-ClinicalImaging TechnologyResolutionTranslatingTranslationsBiopsyClinical ResearchMagnetic Resonance ImagingDesignHormone TherapyMagnetic Resonance SpectroscopyCancer ImagingClinical ManagementAnticancer ResearchIndolent
Grant awards (12)
CLINICAL TRANSLATION OF HYPERPOLARIZED 13C-UREA FOR CANCER MR MOLECULAR IMAGING$678,703
R01 · FY2018 · CA
Translating HP 13C MRI as a Novel Paradigm for Assessing Drug Target Inhibition$657,821
R01 · FY2018 · CA
CLINICAL TRANSLATION OF HYPERPOLARIZED 13C-UREA FOR CANCER MR MOLECULAR IMAGING$684,591
R01 · FY2017 · CA
Translating HP 13C MRI as a Novel Paradigm for Assessing Drug Target Inhibition$657,802
R01 · FY2017 · CA
Translating HP 13C MRI as a Novel Paradigm for Assessing Drug Target Inhibition$655,718
R01 · FY2016 · CA
Translating HP 13C MRI as a Novel Paradigm for Assessing Drug Target Inhibition$641,305
R01 · FY2015 · CA
Translating HP 13C MRI as a Novel Paradigm for Assessing Drug Target Inhibition$650,008
R01 · FY2014 · CA
Translation and Evaluation of a Multiparametric Prostate Cancer 3T Exam$481,279
R01 · FY2014 · CA
Translation and Evaluation of a Multiparametric Prostate Cancer 3T Exam$495,937
R01 · FY2013 · CA
Translation and Evaluation of a Multiparametric Prostate Cancer 3T Exam$497,610
R01 · FY2012 · CA
Translation and Evaluation of a Multiparametric Prostate Cancer 3T Exam$555,502
R01 · FY2011 · CA
Translation and Evaluation of a Multiparametric Prostate Cancer 3T Exam$582,287
R01 · FY2010 · CA